Mode
Text Size
Log in / Sign up

Systemic corticosteroids led to anatomic regression of optic nerve head granuloma in sarcoidosisCorticosteroids help shrink a rare eye growth in sarcoidosis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that systemic corticosteroids may lead to anatomic regression of sarcoid-associated optic nerve head granuloma.

This case report and literature review examines the management of sarcoidosis-associated optic nerve head granuloma. The report describes a 31-year-old woman who presented with an optic nerve head granuloma. Following the initiation of systemic corticosteroid treatment, the lesion gradually regressed, accompanied by the disappearance of lesion-associated abnormal flow signals. Throughout the follow-up period, the patient's visual acuity remained stable at 20/20.

The authors highlight that multimodal imaging is valuable for the early recognition, assessment of treatment response, and longitudinal monitoring of these lesions. However, the evidence is limited by the single case report format and the review of limited literature. Because of the small sample size and the nature of the report, the certainty of the findings is low.

Clinically, while the case suggests that corticosteroid-based systemic therapy may be considered for these patients, the results are based on a single individual. Multimodal imaging remains a useful tool for monitoring progression and response in sarcoidosis-related optic nerve pathology.

How this fits prior evidence

This case report addresses a gap in clinical evidence regarding the specific management of sarcoidosis-associated optic nerve head granuloma. While the report confirms that corticosteroids are a first-line treatment for other conditions like shrinking lung syndrome in systemic lupus erythematosus, this specific case provides a single instance of corticosteroid-induced regression in sarcoidosis-related optic nerve lesions.

Imagine dealing with a rare condition like sarcoidosis, which can cause unusual growths in the eye. For one 31-year-old woman, this growth was located on her optic nerve head. This specific type of growth can threaten vision, making early detection and monitoring vital for her long-term health.

Doctors treated her with systemic corticosteroids, which are a type of steroid medication. During her treatment, the growth on her optic nerve began to shrink. At the same time, imaging showed that the abnormal blood flow signals caused by the growth were disappearing. Throughout this entire process, her vision remained perfect at 20/20.

While this specific case shows how steroids can help, it is important to remember that this was a single case report. Because it only involved one patient, the evidence is currently limited. However, the use of different types of imaging helps doctors see these changes early and track how well a patient is responding to treatment.

What this means for you:
Steroid treatment helped shrink a rare eye growth while a patient maintained perfect vision.

Common questions

What happened to the patient's vision during treatment?

The patient's vision remained at 20/20 throughout the entire follow-up period. Even as the doctors monitored the growth on her optic nerve, her vision did not change or decline.

How did the medication affect the eye condition?

The patient received systemic corticosteroids. Following this treatment, the growth on her optic nerve head gradually regressed. Imaging also showed that the abnormal blood flow signals associated with the lesion disappeared during the treatment.

Is this a common way to treat sarcoidosis of the eye?

Because this was a single case report, the evidence is currently limited. While the treatment worked for this specific patient, you should talk to your doctor to see if this approach is right for your specific situation.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
BackgroundSarcoidosis is a multisystem granulomatous disorder of unclear etiology, histopathologically characterized by noncaseating granulomas. Ocular involvement is among the most common extrapulmonary manifestations, whereas optic nerve involvement occurs in fewer than 5% of cases. Direct granulomatous infiltration of the optic nerve represents the rarest form of optic nerve involvement. We report a rare case of a sarcoidosis-associated optic nerve head granuloma with prominent overlying vessels and describe its multimodal imaging features, clinical course, and treatment response, with a review of the clinical spectrum of sarcoid optic nerve head granulomas reported in the English-language literature.Case presentationA 31-year-old woman presented with floaters in the left eye. Best-corrected visual acuity was 20/20 in both eyes. Fundus examination of the left eye revealed a white elevated optic nerve head lesion with fine tortuous surface vessels, accompanied by vitreous inflammatory haze, retinal periphlebitis, and candle-wax drippings. Fundus fluorescein angiography demonstrated early filling of lesion-associated vessels with marked late leakage, and optical coherence tomography angiography detected abnormal flow signals corresponding to the lesion. Additionally, chest computed tomography revealed bilateral hilar lymphadenopathy, and transbronchial lung biopsy demonstrated chronic granulomatous inflammation with multinucleated giant cells and no definite necrosis. The overall findings supported the diagnosis of sarcoidosis. The lesion initially progressed after the patient declined corticosteroid therapy, but gradually regressed following systemic corticosteroid treatment, with parallel disappearance of the lesion-associated abnormal flow signals. At the final follow-up, the lesion had completely regressed, leaving only a thin gliotic membrane, while visual acuity remained 20/20 throughout the entire follow-up.ConclusionAlthough rare, sarcoid optic nerve head granuloma is a highly suggestive ocular manifestation that may be the presenting sign of systemic sarcoidosis and can mimic infectious or neoplastic optic disc mass lesions. Multimodal imaging is valuable for early recognition, assessment of treatment response, and longitudinal monitoring. Once the diagnosis is established, corticosteroid-based systemic therapy may be considered. In this case, systemic corticosteroid therapy was associated with anatomic regression of the optic nerve head granuloma, while visual acuity remained stable throughout follow-up.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.